Engrail Therapeutics

Engrail closes $157M series B, fueled by investors' renewed interest in neuropsychiatry
Fierce Biotech
Tue, 03/19/24 - 11:58 am
Engrail Therapeutics
funding
neuropsychiatric
anxiety
depression